Targeting the Non-Canonical NF-?B Pathway in Chronic Lymphocytic Leukemia and Multiple Myeloma (2022)
Attributed to:
Therapeutic targeting of refractory/relapsed diffuse large B-cell lymphoma through systems biology
funded by
FLF
Abstract
No abstract provided
Bibliographic Information
Publication URI: https://www.mdpi.com/2072-6694/14/6/1489
Type: Journal Article/Review
Volume: 14
Parent Publication: Cancers
Issue: 6